Ondřej Kubeček
9PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 16, 2024
The outcome in patients with BRAF-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting.Jindřich Kopecký, Marek Pásek, Radek Lakomý
|Dec 24, 2021
Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors.Ondřej Kubeček, Pavla Paterová, Martina Novosadová
|Sep 28, 2021
Combined Therapy of Locally Advanced Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas: State of the Art and Aspects of Predictive Factors.Milan Vošmik, Jindřich Kopecký, Stanislav John
|Aug 26, 2021
Clinicopathological Characteristics and Prognostic Factors in Ovarian Metastases from Right- and Left-Sided Colorectal Cancer.Ondřej Kubeček, Jan Laco, Jiří Špaček
|Nov 20, 2020
Erratum: Filip, S.; et al. Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics 2020, 12, 940.Stanislav Filip, Ondřej Kubeček, Jiří Špaček
|Oct 03, 2020
Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years.Stanislav Filip, Ondřej Kubeček, Jiří Špaček
Pageof 2
Frequent Collaborators
6 joint publications
Stanislav Filip
2 joint publications
Jiří Špaček
2 joint publications
Jindřich Kopecký
1 joint publications
Jan Laco
1 joint publications
Jaroslav Chládek
1 joint publications
Milan Bláha
1 joint publications
Miroslav Hodek
1 joint publications
Veronika Vymetalkova
1 joint publications
Monika Manethova
1 joint publications
Klara Cervena
